adamantane has been researched along with reserpine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chakrabarti, JK; Hotten, TM; Sutton, S; Tupper, DE | 1 |
| Bivalacqua, TJ; Champion, HC; Coy, DH; Erickson, CC; Kadowitz, PJ; Murphy, WA; Simoneaux, ML | 1 |
2 other study(ies) available for adamantane and reserpine
| Article | Year |
|---|---|
Adamantane and protoadamantanealkanamines as potential anti-Parkinson agents.
Topics: Adamantane; Amines; Animals; Antiparkinson Agents; Body Temperature; Bridged-Ring Compounds; Lethal Dose 50; Mice; Motor Activity; Rats; Reserpine | 1976 |
Proadrenomedullin NH2-terminal 20 peptide has cAMP-mediated vasodilator activity in the mesenteric vascular bed of the cat.
Topics: Adamantane; Adrenomedullin; Animals; Cats; Cyclic AMP; Denervation; Enzyme Inhibitors; Female; Male; Mesenteric Artery, Superior; Morpholines; NG-Nitroarginine Methyl Ester; Peptide Fragments; Peptides; Phentolamine; Proteins; Purinones; Pyrrolidinones; Reserpine; Rolipram; Sympathetic Nervous System; Sympatholytics; Vasodilation | 1996 |